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Alzhcitner’r Discnsz CAD) is a brain-spcoific diseaxc that 
results in scvcrc eoynitivc impairment nird ix ChurWrritretl by 
an obundnnse of nwitic piques and ncurofibrillary ranglcx 
and rhc sclcctive dcgeocrution QP ncrvc cells located mainly in 
the: ccrcbral CQrrcx snd hippocampus, The condition, its 
possible eauscs and physiaehemical manifestations arc: 
summarized in 30 short Chi~ptCrs yrollpd into 7 major 
thcmcs; (i) fhc molsculnr biology of rhc amyloid fibril 
prrcursar protein, (ii) the eharacreriratiarr of paired helical 
filonrcnrs, (iii) animal models and species spccifieiry far AD, 
(iv) regional specificity of the pathology, (v) degcncrntion and 
neuropktsticity, (vi) IIOn-ncuronal invobdcment in AR 
pathology, and (vii) genetics of AD. Molecular handles for the 
study of AD are the accumulation of A4 protein and 
neurofibrillnry tangles, and a major proportion of the book 
concerns the role of the A4, or beta protein, in AD. Possible 
cxplnnrtionn 0I’ the weumulnrion caf the protein fragment are 
clixcwwd in relatioli to the t&t that the ame protein ix PQo~~ci 
abundtmtly in ik~n’% #ynclrwrr~c brain (triramy 21) and the 
gene for the A4 prcctrrser is located on chromosome 21. The 
presence of p&cd hclicwl filaments msy bc a further example 
of the accumtrtation af aberrant pQ)ypCptidfm psrriet&irly ax 
rhcy appear tQ be I’lagged far potentinl destruction by their 
conjugntion with llbi~uitin, (icnc dosage, csntrd ST gene 
cxprcsian and prstein etltsboiirm are areas prabed 8s 
causative: lactsrs far thsre changes in brnin protein 
biochemistry. The presence of a protcase inhibitor sequence 
on the A4 preeursar ir auggcstiw that proteolytie functians 
mny be impurtant in RD. Scrnpic with the ‘inkc~ivc’ protein 
or prion and in~llse rrisomy 16 are prcdcntcd as possible 
modctr of neurod~g~l~cra~~on. Howctdcr it remains to be 
clarified whcthcr the accumulated aberrant polypcptidcs so 
characteristic of wurodsgznrrntion are the direct causal 
agents of AD, or whether these apparently incompletely 
degraded polypeptidcs are non-paihological symptoms of an 
unidcntificd ncurotaxic factor which also provokes their 
accumulation. 
A.R, Migkiss 
Transmembrane SignaIling, Intracellulnr Mcssengw and Implications for Drug Development; Edited by Stefan 
R. Nahorski; John Wiley, Chichestcr, 1990; xvi + 248 pages; E39.50 
As an overfrequent participant at scientific meetings, I do not 
care to have the repayment of my fare or accomodation being 
made condit.ional on the delivery of a script. I sense that many 
others who delight in presenting their work and ideas for 
discussion at meetings share my dissatisfaction with a form of 
publication whicn is generally inaccessible to most readers 
(i,e. rarely do these appear in a sequence of a serial 
publication), almost invariably out of date (two years is not 
unusual) and very expensive. There are exceptions of course 
and on occasion I have been happy to arrive at important 
meetings or exotic places with my ticket underwritten by a 
paper. Similarly, I can imagine most of those invited to speak 
at the annual Biological Council Symposium on Drug Action 
in the Spring of 1989 were also happy to arrive, script in hand. 
The reason for this is that the meeting was held in the 
magnificent 18th century lecture theatre ai, the Royal 
Institution near Piccadilly in London, made famous in earlier 
times by such as Humphrey Davy, Michael Faraday and John 
(‘Blue Sky’) Tyndall (and which should not to be confused 
with the Royal Society whose facilities pale in comparison). 
So, what have WC got? The volume at just under 250 pages 
comprises 14 chapters and encompasses most of the main 
areas of intcrcst expressed in the title. Mainly this means the 
mechanisms by which the concentrations of cyclic AMP and 
Ca2’ insi,de cells arc regulated and appropriately the 
consider-ation of subsequent events (e.g. regulation of protein 
phosphorylation and dephosphorylation) is excluded. There is 
nothing on retinal transduction and there are a few other 
obvious omissions. A number of leading laboratories arc 
represented by authorship and doubtless anyone working in 
the area will find something of interest. More than this, a 
number of the chapters are well introduced with nice historical 
sections (e.g. Regan, Caron and Lefkowitz on adrenergic 
receptors, Buckley on muscarinic receptors). At a timr when 
all is being swept aside by cloning techniques, I suspect that 
these introductory words will have more staying power than 
anything else and in this respect the artic!es will serve those 
students who require a historical background. The best 
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